Hudson Bay Capital Management
KYNB

Hudson Bay Capital Management’s Kyntra Bio KYNB Stock Holding History

Hudson Bay Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,039
Closed -$15.8K – 1475
2025
Q1 		$15.8K Buy
+2,039
New +$24.4K ﹤0.01% 1237
2024
Q2 		– Sell
-14,400
Closed -$846K – 833
2024
Q1 		$846K Buy
+14,400
New +$620K ﹤0.01% 553
2023
Q1 		– Sell
-5,000
Closed -$2M – 901
2022
Q4 		$2M Sell
5,000
-1,000
-17% -$383K 0.02% 608
2022
Q3 		$1.95M Sell
6,000
-1,300
-18% -$419K 0.02% 746
2022
Q2 		$1.93M Buy
7,300
+1,700
+30% +$434K 0.01% 813
2022
Q1 		$1.68M Buy
5,600
+200
+4% +$69.7K 0.02% 738
2021
Q4 		$1.9M Sell
5,400
-200
-4% -$62.3K 0.02% 704
2021
Q3 		$1.43M Buy
+5,600
New +$1.98M 0.02% 693
2020
Q4 		– Sell
-2,400
Closed -$2.47M – 624
2020
Q3 		$2.47M Sell
2,400
-1,972
-45% -$2.12M 0.04% 332
2020
Q2 		$4.43M Buy
4,372
+3,459
+379% +$3.21M 0.08% 215
2020
Q1 		$793K Buy
+913
New +$908K 0.02% 351

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Hudson Bay Capital Management's KYNB Position: Q2 2025 in Review

Hudson Bay Capital Management sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 2,039 shares — an estimated $15.8K sold.

Hudson Bay Capital Management first reported a position in KYNB in Q1 2020 and held it in 11 quarters. The position peaked at $4.43M in Q2 2020. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.

  • Hudson Bay Capital Management reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 2,039 Kyntra Bio shares in Q2 2025, an estimated $15.8K.
  • Hudson Bay Capital Management first reported a position in Kyntra Bio in Q1 2020 and held it in 11 quarters.
  • Hudson Bay Capital Management's Kyntra Bio position peaked at $4.43M in Q2 2020.
  • 30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.

Based on Hudson Bay Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.